StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis r&d expenses

Research and development expenses are spending on new products and technology.

Scynexis's R&D Expenses for the twelve months ending Jun 30, 2026 was $26.24M, up 6.4% year over year. For fiscal 2025 it was $22.28M, down 15.6% from the year before. Over ten years it grew 3.1% a year on average. The highest annual figure on record is $38.39M in fiscal 2019.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.28M-15.6%
FY2024Dec 31, 2024$26.41M-14.6%
FY2023Dec 31, 2023$30.93M+13.5%
FY2022Dec 31, 2022$27.26M+14.7%
FY2021Dec 31, 2021$23.77M-34.9%
FY2020Dec 31, 2020$36.52M-4.9%
FY2019Dec 31, 2019$38.39M+78.1%
FY2018Dec 31, 2018$21.56M+17.6%
FY2017Dec 31, 2017$18.33M-8.7%
FY2016Dec 31, 2016$20.08M+22.1%
FY2015Dec 31, 2015$16.44M+98.4%
FY2014Dec 31, 2014$8.29M+89.9%
FY2013Dec 31, 2013$4.36M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.89M-45.5%
Q1 FY2026Mar 31, 2026$12.35M+140.2%
Q4 FY2025Dec 31, 2025$4.55M+5.4%
Q3 FY2025Sep 30, 2025$5.45M-32.5%
Q2 FY2025Jun 30, 2025$7.14M+4.9%
Q1 FY2025Mar 31, 2025$5.14M-28.7%
Q4 FY2024Dec 31, 2024$4.31M-59.2%
Q3 FY2024Sep 30, 2024$8.07M+24.9%
Q2 FY2024Jun 30, 2024$6.81M-3.3%
Q1 FY2024Mar 31, 2024$7.21M+5.5%
Q4 FY2023Dec 31, 2023$10.59M+34.9%
Q3 FY2023Sep 30, 2023$6.47M+0.6%
Q2 FY2023Jun 30, 2023$7.04M-1.3%
Q1 FY2023Mar 31, 2023$6.84M+19.2%
Q4 FY2022Dec 31, 2022$7.85M+2.1%
Q3 FY2022Sep 30, 2022$6.43M+46.1%
Q2 FY2022Jun 30, 2022$7.13M+50.6%
Q1 FY2022Mar 31, 2022$5.74M-17.5%
Q4 FY2021Dec 31, 2021$7.69M-24.3%
Q3 FY2021Sep 30, 2021$4.40M-45.2%
Q2 FY2021Jun 30, 2021$4.73M-44.1%
Q1 FY2021Mar 31, 2021$6.95M-29.6%
Q4 FY2020Dec 31, 2020$10.16M-7.3%
Q3 FY2020Sep 30, 2020$8.03M-13.4%
Q2 FY2020Jun 30, 2020$8.47M-0.1%
Q1 FY2020Mar 31, 2020$9.87M+1.9%
Q4 FY2019Dec 31, 2019$10.96M+63.5%
Q3 FY2019Sep 30, 2019$9.28M+135.9%
Q2 FY2019Jun 30, 2019$8.47M+51.3%
Q1 FY2019Mar 31, 2019$9.68M+81.8%
Q4 FY2018Dec 31, 2018$6.70M+24.1%
Q3 FY2018Sep 30, 2018$3.93M-11.8%
Q2 FY2018Jun 30, 2018$5.60M+25.9%
Q1 FY2018Mar 31, 2018$5.33M+32.5%
Q4 FY2017Dec 31, 2017$5.40M+42.7%
Q3 FY2017Sep 30, 2017$4.46M-8.8%
Q2 FY2017Jun 30, 2017$4.45M–
Q1 FY2017Mar 31, 2017$4.02M–
Q4 FY2016Dec 31, 2016$3.78M–
Q3 FY2016Sep 30, 2016$4.89M–

More Scynexis figures

See a number that looks wrong?